1. Home
  2. ONCO vs EVAX Comparison

ONCO vs EVAX Comparison

Compare ONCO & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONCO
  • EVAX
  • Stock Information
  • Founded
  • ONCO 2018
  • EVAX 2008
  • Country
  • ONCO United States
  • EVAX Denmark
  • Employees
  • ONCO N/A
  • EVAX N/A
  • Industry
  • ONCO Biotechnology: Pharmaceutical Preparations
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ONCO Health Care
  • EVAX Health Care
  • Exchange
  • ONCO Nasdaq
  • EVAX Nasdaq
  • Market Cap
  • ONCO 1.8M
  • EVAX 10.8M
  • IPO Year
  • ONCO 2022
  • EVAX 2021
  • Fundamental
  • Price
  • ONCO $4.85
  • EVAX $2.45
  • Analyst Decision
  • ONCO
  • EVAX Strong Buy
  • Analyst Count
  • ONCO 0
  • EVAX 2
  • Target Price
  • ONCO N/A
  • EVAX $10.00
  • AVG Volume (30 Days)
  • ONCO 232.8K
  • EVAX 115.3K
  • Earning Date
  • ONCO 06-12-2025
  • EVAX 08-13-2025
  • Dividend Yield
  • ONCO N/A
  • EVAX N/A
  • EPS Growth
  • ONCO N/A
  • EVAX N/A
  • EPS
  • ONCO N/A
  • EVAX N/A
  • Revenue
  • ONCO $1,925,313.00
  • EVAX $3,293,000.00
  • Revenue This Year
  • ONCO N/A
  • EVAX N/A
  • Revenue Next Year
  • ONCO N/A
  • EVAX N/A
  • P/E Ratio
  • ONCO N/A
  • EVAX N/A
  • Revenue Growth
  • ONCO 153.70
  • EVAX 2555.64
  • 52 Week Low
  • ONCO $3.82
  • EVAX $1.20
  • 52 Week High
  • ONCO $1,190.00
  • EVAX $17.75
  • Technical
  • Relative Strength Index (RSI)
  • ONCO 44.27
  • EVAX 50.23
  • Support Level
  • ONCO $4.40
  • EVAX $2.35
  • Resistance Level
  • ONCO $5.10
  • EVAX $2.60
  • Average True Range (ATR)
  • ONCO 0.62
  • EVAX 0.27
  • MACD
  • ONCO 0.08
  • EVAX -0.05
  • Stochastic Oscillator
  • ONCO 30.25
  • EVAX 34.35

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.

About EVAX Evaxion Biotech

Evaxion AS is in the field of oncology. It used the AI-Immunology platform.

Share on Social Networks: